89 related articles for article (PubMed ID: 30030068)
1. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022.
Kandeel A; Fahim M; Abukamar S; BahaaEldin H; Abuelsood H; Samy S; Deghedy O; Sheta A; Naguib A; El Guindy N; Youssef A; Kamel R; Afifi S; El-Kassas M; Abdelghaffar K
Liver Int; 2024 Apr; 44(4):955-965. PubMed ID: 38291807
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt.
Schwarzinger M; Dewedar S; Rekacewicz C; Abd Elaziz KM; Fontanet A; Carrat F; Mohamed MK
Hepatology; 2004 Dec; 40(6):1434-41. PubMed ID: 15565610
[TBL] [Abstract][Full Text] [Related]
4. Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study.
Walker JG; Kuchuloria T; Sergeenko D; Fraser H; Lim AG; Shadaker S; Hagan L; Gamkrelidze A; Kvaratskhelia V; Gvinjilia L; Aladashvili M; Asatiani A; Baliashvili D; Butsashvili M; Chikovani I; Khonelidze I; Kirtadze I; Kuniholm MH; Otiashvili D; Sharvadze L; Stvilia K; Tsertsvadze T; Zakalashvili M; Hickman M; Martin NK; Morgan J; Nasrullah M; Averhoff F; Vickerman P
Lancet Glob Health; 2020 Feb; 8(2):e244-e253. PubMed ID: 31864917
[TBL] [Abstract][Full Text] [Related]
5. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village.
Ahmed OA; Safwat E; Khalifa MO; Elshafie AI; Fouad MHA; Salama MM; Naguib GG; Eltabbakh MM; Sherief AF; Abd-Elsalam S
Int J Hepatol; 2018; 2018():9616234. PubMed ID: 29755792
[TBL] [Abstract][Full Text] [Related]
6. Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030.
Schaefer B; Viveiros A; Al-Zoairy R; Blach S; Brandon S; Razavi H; Dorn L; Finkenstedt A; Effenberger M; Graziadei I; Sarcletti M; Tilg H; Zoller H
PLoS One; 2018; 13(7):e0200750. PubMed ID: 30001427
[TBL] [Abstract][Full Text] [Related]
7. Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas.
Chen CH; Hsu NT; Chen IC; Chang TS; Cheng S; Cheng SY; Chen HM; Harn MR; Liu CK; Yang MT; Lu SL; Tseng CM; Lu SN
J Formos Med Assoc; 2024 May; 123(5):613-619. PubMed ID: 38195318
[TBL] [Abstract][Full Text] [Related]
8. "Test, Listen, Cure" (TLC) Hepatitis C Community Awareness Campaign.
Coughlin SS
JMIR Res Protoc; 2015 Feb; 4(1):e13. PubMed ID: 25677459
[TBL] [Abstract][Full Text] [Related]
9. Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan.
Hu TH; Luh DL; Tsao YY; Lin TY; Chang CJ; Su WW; Yang CC; Yang CJ; Chen HP; Liao PY; Su SL; Chen LS; Hsiu-Hsi Chen T; Yeh YP;
Am J Gastroenterol; 2024 May; 119(5):883-892. PubMed ID: 38084857
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.
Mera J; Williams MB; Essex W; McGrew KM; Boeckman L; Gahn D; Miller A; Durham D; Fox J; David C; Ritter T; Jones S; Bouse S; Galvani A; Ward JW; Drevets DA; Carabin H
JAMA Netw Open; 2020 Dec; 3(12):e2030427. PubMed ID: 33337496
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis C in Western Canada: a survey of practice patterns among gastroenterologists in Alberta and British Columbia.
Pai R; Ramji A; Lee SS; Wong WW; Yoshida EM
Can J Gastroenterol Hepatol; 2014 Jan; 28(1):e1-4. PubMed ID: 24212914
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat.
Rocca LG; Yawn BP; Wollan P; Kim WR
Ann Fam Med; 2004; 2(2):116-24. PubMed ID: 15083850
[TBL] [Abstract][Full Text] [Related]
13. Case control study to identify risk factors for acute hepatitis C virus infection in Egypt.
Kandeel AM; Talaat M; Afifi SA; El-Sayed NM; Abdel Fadeel MA; Hajjeh RA; Mahoney FJ
BMC Infect Dis; 2012 Nov; 12():294. PubMed ID: 23145873
[TBL] [Abstract][Full Text] [Related]
14. The burden of HCV among prevalent hemodialysis patients after the National Egyptian HCV Eradication program.
Sarhan II; ELSharkawy MM; El Gaafary MM; Hendam DMT; Gouda K
Egypt J Immunol; 2024 Apr; 31(2):112-121. PubMed ID: 38615268
[TBL] [Abstract][Full Text] [Related]
15. Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.
Mitruka K; Tsertsvadze T; Butsashvili M; Gamkrelidze A; Sabelashvili P; Adamia E; Chokheli M; Drobeniuc J; Hagan L; Harris AM; Jiqia T; Kasradze A; Ko S; Qerashvili V; Sharvadze L; Tskhomelidze I; Kvaratskhelia V; Morgan J; Ward JW; Averhoff F
MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(28):753-7. PubMed ID: 26203628
[TBL] [Abstract][Full Text] [Related]
16. Preventing hepatocellular carcinoma in Egypt: results of a Pilot Health Education Intervention Study.
Saleh DA; Amr S; Jillson IA; Wang JH; Crowell N; Loffredo CA
BMC Res Notes; 2015 Aug; 8():384. PubMed ID: 26319021
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C identification and treatment in rural Pennsylvania, USA.
Stainbrook T; Elliott K; Powell A; Simpson MA; Bash M
Prev Med Rep; 2021 Dec; 24():101526. PubMed ID: 34976603
[TBL] [Abstract][Full Text] [Related]
18. No Patient Left Behind: A Novel Paradigm to Fulfill Hepatitis C Virus Treatment for Rural Patients.
Gormley MA; Moschella P; Cordero-Romero S; Wampler WR; Allison M; Kitzmiller K; Estes L; Heo M; Litwin AH; Roth P
Open Forum Infect Dis; 2024 May; 11(5):ofae206. PubMed ID: 38737428
[TBL] [Abstract][Full Text] [Related]
19. Identifying missed opportunities for hepatitis C virus antenatal testing and diagnosis in England.
Hibbert M; Simmons R; Sabin CA; Mandal S; Desai M
J Viral Hepat; 2024 Mar; 31(3):131-136. PubMed ID: 38178637
[TBL] [Abstract][Full Text] [Related]
20. Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374).
Meszaros M; Coursier S; Nagot N; Moulis L; Taourel P; Pages-Bouic E; Fabre-Demard N; Trentini M; Pageaux GP; Donnadieu H
J Viral Hepat; 2024 May; ():. PubMed ID: 38749911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
